Article
Population pharmacokinetics of lenalidomide in Chinese patients with influence of genetic polymorphisms of ABCB1
2023-10-17
Abstract excerpt
<h4>Objective: </h4> Affected by differences in the pharmacokinetics (PK) of lenalidomide, the toxicity of lenalidomide varies among different patients, with severe toxicity leading to dose reduction or discontinuation. The differences in the PK of lenalidomide may be related to factors such as patients’ physiological characteristics, pathological characteristics and gene polymorphisms et al., which may also affec...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e7c5d87e-9b71-50c5-99e1-7d99cd77f5c0
- DOI
- 10.21203/rs.3.rs-3421464/v1
